Shilpa Ray

Publikationer
Forskningsbidrag
Populärvetenskap och samverkan

Artiklar

Article: SCIENTIFIC REPORTS. 2024;14(1):17820
Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV
Narayanan A; Kieri O; Vesterbacka J; Manoharan L; Chen P; Ghorbani M; Ljunggren H-G; Chen MS; Aleman S; Soennerborg A; Ray S; Nowak P
Article: NPJ BIOFILMS AND MICROBIOMES. 2023;9(1):104
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
Ray S; Narayanan A; Vesterbacka J; Blennow O; Chen P; Gao Y; Gabarrini G; Ljunggren H-G; Buggert M; Manoharan L; Chen MS; Aleman S; Sonnerborg A; Nowak P
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023;61(5):106792
Naturally occurring dipeptide from elite controllers with dual anti-HIV-1 mechanism
Cena-Diez R; Narayanan A; Ray S; van de Klundert M; Rodriguez JE; Nilvebrant J; Nygren P-A; Vegvari A; van Domselaar R; Sonnerborg A
Article: PROTEIN SCIENCE. 2022;31(4):835-849
Structural investigation on SPI-6-associated Salmonella typhimurium VirG-like stress protein that promotes pathogen survival in macrophages
Ray S; Pandey NK; Kushwaha GS; Das S; Ganguly AK; Vashi N; Kumar D; Suar M; Bhavesh NS
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:1079995
Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV
Ghorbani M; Al-Manei K; Naud S; Healy K; Gabarrini G; Sobkowiak MJ; Chen P; Ray S; Akber M; Muschiol S; Bogdanovic G; Bergman P; Ljungman P; Buggert M; Ljunggren H-G; Pin E; Nowak P; Aleman S; Saellberg Chen M
Article: JOURNAL OF VIROLOGY. 2021;95(18):e0047921-10.1128/jvi.00421
Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a Prevotella Agonist
Sperk M; Ambikan AT; Ray S; Singh K; Mikaeloff F; Diez RC; Narayanan A; Vesterbacka J; Nowak P; Sonnerborg A; Neogi U
Article: ACS INFECTIOUS DISEASES. 2021;7(5):1104-1115
Altered Gut Microbiome under Antiretroviral Therapy: Impact of Efavirenz and Zidovudine
Ray S; Narayanan A; Giske CG; Neogi U; Sonnerborg A; Nowak P
Article: FRONTIERS IN MICROBIOLOGY. 2021;12:667718
Whole-Genome Metagenomic Analysis of the Gut Microbiome in HIV-1-Infected Individuals on Antiretroviral Therapy
Bai X; Narayanan A; Nowak P; Ray S; Neogi U; Sonnerborg A
Journal article: VIRULENCE. 2020;11(1):247-259
A ROD9 island encoded gene in Salmonella Enteritidis plays an important role in acid tolerance response and helps in systemic infection in mice.
Das S; Ray S; Arunima A; Sahu B; Suar M; Suar M
Journal article: VIRULENCE. 2020;11(1):295-314
RpoS-regulated SEN1538 gene promotes resistance to stress and influences Salmonella enterica serovar enteritidis virulence.
Arunima A; Swain SK; Ray S; Prusty BK; Suar M; Suar M
Journal article: VIRULENCE. 2018;9(1):348-362
Identification of a novel gene in ROD9 island of Salmonella Enteritidis involved in the alteration of virulence-associated genes expression.
Das S; Ray S; Ryan D; Sahu B; Suar M; Suar M
Journal article: GUT PATHOGENS. 2018;10:30
Identification of a new alanine racemase in Salmonella Enteritidis and its contribution to pathogenesis.
Ray S; Das S; Panda PK; Suar M
Journal article: SCIENTIFIC REPORTS. 2016;6:38204
The Hha-TomB Toxin-Antitoxin System Shows Conditional Toxicity and Promotes Persister Cell Formation by Inhibiting Apoptosis-Like Death in S. Typhimurium.
Jaiswal S; Paul P; Padhi C; Ray S; Ryan D; Dash S; Suar M
Journal article: APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 2015;81(23):8054-8065
Global transcriptome and mutagenic analyses of the acid tolerance response of Salmonella enterica serovar Typhimurium.
Ryan D; Pati NB; Ojha UK; Padhi C; Ray S; Jaiswal S; Singh GP; Mannala GK; Schultze T; Chakraborty T; Suar M
Journal article: VACCINE. 2015;33(15):1880-1889
Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt W-D; Suar M
Journal article: GUT PATHOGENS. 2015;7:24
The O-antigen negative ∆wbaV mutant of Salmonella enterica serovar Enteritidis shows adaptive resistance to antimicrobial peptides and elicits colitis in streptomycin pretreated mouse model.
Jaiswal S; Pati NB; Dubey M; Padhi C; Sahoo PK; Ray S; Arunima A; Mohakud NK; Suar M
Journal article: VIRULENCE. 2014;5(2):311-320
TTSS2-deficient hha mutant of Salmonella Typhimurium exhibits significant systemic attenuation in immunocompromised hosts.
Vishwakarma V; Pati NB; Ray S; Das S; Suar M

Alla övriga publikationer

Preprint: RESEARCH SQUARE. 2024
Exploring the interplay between antiretroviral therapy and the gut-oral microbiome axis in people living with HIV
Narayanan A; Kieri O; Vesterbacka J; Manoharan L; Chen P; Ghorbani M; Ljunggren H-G; Chen MS; Aleman S; Sönnerborg A; Ray S; Nowak P
Preprint: RESEARCH SQUARE. 2023
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
Ray S; Narayanan A; Vesterbacka J; Blennow O; Chen P; Gao Y; Gabarrini G; Ljunggren H-G; Buggert M; Manoharan L; Chen M; Aleman S; Sönnerborg A; Nowak P
Preprint: RESEARCH SQUARE. 2020
Novel mechanism of HIV elite control by enriching gut dipeptides as HIV-1 antagonist but Prevotella agonist
Sperk M; Ambikan A; Ray S; Singh K; Mikaeloff F; Diez RC; Narayanan A; Vesterbacka J; Nowak P; Sönnerborg A; Neogi U

Forskningsbidrag

Optimizing Immunological Responses to Vaccination and Advancing HIV Cure Strategies through Gut Microbiome.
Region Stockholm (CIMED Senioransökan)
1 January 2025 - 31 December 2027
Identification of novel non-antibiotic bactericidal agents to fight antimicrobial resistant bacteria from patients with different chronic infections
Region Stockholm (CIMED Junioransökan)
1 January 2025 - 31 December 2027
Impact of metabolites and bacterial signatures on gut epithelial integrity in HIV infected Elite controllers
KI - Karolinska Institutet Research Foundation Grants
1 January 2025 - 31 December 2025
Identification of a Novel non-antibiotic Bactericidal agent to fight antimicrobial resistance
Swedish Research Council
1 January 2023 - 31 December 2025
Are microbiome changes responsible for the weight gain in individuals treated with dolutegravir?
Stiftelsen Läkare mot AIDS Forskningsfond
1 November 2021 - 31 July 2022
Are microbiome changes responsible for the weight gain in individuals treated with dolutegravir?
Karolinska Institutet Foundation for Virus Research
1 April 2021 - 31 December 2022
Antivirals in the war against multidrug resistant bacteria
Åke Wibergs Stiftelse
1 January 2021 - 31 December 2023
Can antiretroviral drugs be used to treat antibiotic-resistant bacteria?
KI - Karolinska Institutet Research Foundation Grants
1 January 2021 - 1 January 2022

Artiklar

Alla övriga publikationer

Forskningsbidrag

Nyheter från KI

Kalenderhändelser från KI